Align Technology, Inc.

Healthcare

NASDAQ:ALGN · NASDAQ Global Select

Market Cap $12.43B Beta 1.67 P/E (TTM) 28.8

$182.08 -3.34%

-$5.99 today

52W Low $122.00High $208.31

Vol 1.89M · Avg 1.05M

EPS (TTM) $6.02Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-0.73%

Period High

$207.19

Period Low

$124.88

Latest

$182.08

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Exelixis, Inc.

NASDAQ:EXEL

$13.18B

Penumbra, Inc.

NYSE:PEN

$12.44B

Revvity, Inc.

NYSE:RVTY

$10.91B

BioMarin Pharmaceutical Inc.

NASDAQ:BMRN

$10.63B

Globus Medical, Inc.

NYSE:GMED

$10.17B

The Ensign Group, Inc.

NASDAQ:ENSG

$9.11B

Bio-Rad Laboratories, Inc.

NYSE:BIO

$7.70B

Qiagen N.V.

NYSE:QGEN

$7.54B

Hims & Hers Health, Inc.

NYSE:HIMS

$7.11B

What is the latest ALGN filing?

The latest filing shown is SD dated May 29, 2026.

How many recent filings does ALGN have?

Intrinsic Alpha currently shows 20 recent filings for ALGN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.